Sentinel surveillance, viral shedding, clinical characteristics and outcomes of confirmed and suspected hospitalized cases of COVID-19/SARS-CoV-2 infection in the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance Network
- Funded by Canadian Institutes of Health Research (CIHR), Health Canada
- Total publications:2 publications
Grant number: 170724
Grant search
Key facts
Disease
COVID-19Start & end year
20202021Known Financial Commitments (USD)
$748,262.25Funder
Canadian Institutes of Health Research (CIHR), Health CanadaPrincipal Investigator
Shelly Ann McNeilResearch Location
CanadaLead Research Institution
Dalhousie University (Nova Scotia) MedicineResearch Priority Alignment
N/A
Research Category
Clinical characterisation and management
Research Subcategory
Prognostic factors for disease severity
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Not applicable
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
The Canadian Immunization Research Network's (CIRN) Serious Outcomes Surveillance (SOS) Network has been conducting influenza surveillance in Canadian hospitals for the past decade. Currently, the SOS Network includes hospitals across five provinces, representing more than 6,000 inpatient beds. The SOS network is now in a position to contribute to Canada's public health response to the COVID-19 pandemic. Adult patients who are admitted to SOS Network hospitals with suspected COVID-19 illness will be tested for the novel coronavirus as part of their usual care. Patients with confirmed COVID-19 will be enrolled in the surveillance study, meaning that key data about their health will be collected, such as age, sex, chronic conditions, frailty, and COVID-19 risk factors such as travel and contact history. Their health outcomes will be tracked, including the need for treatments such as oxygen therapy, breathing tubes, admission to Intensive Care Units, and survival. A subset of patients will be invited to volunteer for repeated swab testing during the course of their illness to help understand how long people are potentially infectious. All of these efforts will help inform the Public Health Agency of Canada and the scientific community about COVID-19 in Canada and contribute to global efforts to manage this pandemic.
Publicationslinked via Europe PMC
Last Updated:5 days ago
View all publications at Europe PMC